Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis-Reference-Cited by-同舟云学术

Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis

Published:1999-11-26 Issue:8 Volume:81 Page:1385-1391
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Scorilas A,Trangas T,Yotis J,Pateras C,Talieri M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6693404.pdf

Reference47 articles.

1. Alarscon, R, Rupnow, B, Graeber, T, Knox, S & Giaccia, A (1996). Modulation of c-myc activity and apoptosis in vivo. Cancer Res 56: 4315–4319.

2. Alitalo, K & Schwab, M (1986). Oncogene amplification in tumour cells. Adv Cancer Res 47: 235–281.

3. Allred, DC, Harvey, JM & Clark, GM (1998). Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155–168.

4. Ben-Yosef, T, Yanuka, O, Halle, D & Benvenistry, N (1998). Involvement of myc targets in c-myc and N-myc induced human tumours. Oncogene 17: 165–171.

5. Berns, EMJJ, Klijn, JGM, van Puten, WLJ, van Staveren, IL, Portengen, H & Foekens, JA (1992a). c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 52: 1107–1113.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MMTV-LIKE virus and c-myc over-expression are associated with invasive breast cancer;Infection, Genetics and Evolution;2021-07

2. MYC overexpression with its prognostic and clinicopathological significance in breast cancer;Oncotarget;2017-10-05

3. EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2017-08

4. Cooverexpression of EpCAM and c-myc genes in malignant breast tumours;Journal of Genetics;2017-02-22

5. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells;APMIS;2014-08-06